Annual Revenue
$2.82 M
-$18.23 M-86.62%
December 31, 2024
Summary
- As of March 10, 2025, TCRX annual revenue is $2.82 million, with the most recent change of -$18.23 million (-86.62%) on December 31, 2024.
- During the last 3 years, TCRX annual revenue has fallen by -$7.33 million (-72.23%).
- TCRX annual revenue is now -86.62% below its all-time high of $21.05 million, reached on December 31, 2023.
Performance
TCRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$665.00 K
-$384.00 K-36.61%
December 31, 2024
Summary
- As of March 10, 2025, TCRX quarterly revenue is $665.00 thousand, with the most recent change of -$384.00 thousand (-36.61%) on December 31, 2024.
- Over the past year, TCRX quarterly revenue has stayed the same.
- TCRX quarterly revenue is now -90.78% below its all-time high of $7.21 million, reached on December 31, 2023.
Performance
TCRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$2.82 M
-$6.55 M-69.92%
December 31, 2024
Summary
- As of March 10, 2025, TCRX TTM revenue is $2.82 million, with the most recent change of -$6.55 million (-69.92%) on December 31, 2024.
- Over the past year, TCRX TTM revenue has stayed the same.
- TCRX TTM revenue is now -86.62% below its all-time high of $21.05 million, reached on December 31, 2023.
Performance
TCRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TCRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -86.6% | 0.0% | 0.0% |
| 3 y3 years | -72.2% | 0.0% | 0.0% |
| 5 y5 years | - | 0.0% | 0.0% |
TCRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.6% | at low | -90.8% | +24.1% | -86.6% | at low |
| 5 y | 5-year | -86.6% | +159.5% | -90.8% | +129.3% | -86.6% | +871.0% |
| alltime | all time | -86.6% | +159.5% | -90.8% | +129.3% | -86.6% | +871.0% |
TScan Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.82 M(-86.6%) | $665.00 K(-36.6%) | $2.82 M(-69.9%) |
| Sep 2024 | - | $1.05 M(+95.7%) | $9.36 M(-23.3%) |
| Jun 2024 | - | $536.00 K(-5.3%) | $12.20 M(-17.6%) |
| Mar 2024 | - | $566.00 K(-92.2%) | $14.81 M(-29.6%) |
| Dec 2023 | $21.05 M(+55.5%) | $7.21 M(+85.5%) | $21.05 M(+24.3%) |
| Sep 2023 | - | $3.89 M(+23.5%) | $16.93 M(+3.2%) |
| Jun 2023 | - | $3.15 M(-53.7%) | $16.41 M(-5.2%) |
| Mar 2023 | - | $6.80 M(+119.8%) | $17.32 M(+27.9%) |
| Dec 2022 | $13.54 M | $3.10 M(-8.0%) | $13.54 M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $3.36 M(-17.1%) | $13.29 M(+7.7%) |
| Jun 2022 | - | $4.06 M(+34.3%) | $12.34 M(+10.8%) |
| Mar 2022 | - | $3.02 M(+5.9%) | $11.13 M(+9.8%) |
| Dec 2021 | $10.14 M(+834.7%) | $2.85 M(+18.3%) | $10.14 M(+25.5%) |
| Sep 2021 | - | $2.41 M(-15.3%) | $8.08 M(+35.6%) |
| Jun 2021 | - | $2.85 M(+40.5%) | $5.96 M(+91.5%) |
| Mar 2021 | - | $2.03 M(+155.0%) | $3.11 M(+186.8%) |
| Dec 2020 | $1.08 M | - | - |
| Dec 2020 | - | $795.00 K(+174.1%) | $1.08 M(+274.1%) |
| Sep 2020 | - | $290.00 K | $290.00 K |
FAQ
- What is TScan Therapeutics annual revenue?
- What is the all time high annual revenue for TScan Therapeutics?
- What is TScan Therapeutics annual revenue year-on-year change?
- What is TScan Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for TScan Therapeutics?
- What is TScan Therapeutics quarterly revenue year-on-year change?
- What is TScan Therapeutics TTM revenue?
- What is the all time high TTM revenue for TScan Therapeutics?
- What is TScan Therapeutics TTM revenue year-on-year change?
What is TScan Therapeutics annual revenue?
The current annual revenue of TCRX is $2.82 M
What is the all time high annual revenue for TScan Therapeutics?
TScan Therapeutics all-time high annual revenue is $21.05 M
What is TScan Therapeutics annual revenue year-on-year change?
Over the past year, TCRX annual revenue has changed by -$18.23 M (-86.62%)
What is TScan Therapeutics quarterly revenue?
The current quarterly revenue of TCRX is $665.00 K
What is the all time high quarterly revenue for TScan Therapeutics?
TScan Therapeutics all-time high quarterly revenue is $7.21 M
What is TScan Therapeutics quarterly revenue year-on-year change?
Over the past year, TCRX quarterly revenue has changed by $0.00 (0.00%)
What is TScan Therapeutics TTM revenue?
The current TTM revenue of TCRX is $2.82 M
What is the all time high TTM revenue for TScan Therapeutics?
TScan Therapeutics all-time high TTM revenue is $21.05 M
What is TScan Therapeutics TTM revenue year-on-year change?
Over the past year, TCRX TTM revenue has changed by $0.00 (0.00%)